Since decreases in BDNF levels are correlated with negative outcomes after stroke (40), studying the exercise factors that induce BDNF signaling and assessing their neuroprotective abilities may allow us to identify novel endogenous therapeutic agents for stroke. This evidence concerns the gene BDNF and Stroke.